Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34791830)

  • 21. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer.
    Wang W; Lu K; Wang L; Jing H; Pan W; Huang S; Xu Y; Bu D; Cheng M; Liu J; Liu J; Shen W; Zhang Y; Yao J; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):149. PubMed ID: 32611359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
    Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
    BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
    Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
    BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
    Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
    Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
    Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
    Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
    Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
    Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
    Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
    Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
    Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
    Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K
    BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
    Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
    Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
    Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
    Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
    Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
    Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between tissue-based CD3+ T-lymphocyte count and colorectal cancer survival in a prospective cohort of older women.
    Oyenuga M; Vierkant RA; Lynch CF; Pengo T; Tillmans LS; Cerhan JR; Church TR; Lazovich D; Anderson KE; Limburg PJ; Prizment AE
    Mol Carcinog; 2021 Jan; 60(1):15-24. PubMed ID: 33200476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
    Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
    Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twist2 is a valuable prognostic biomarker for colorectal cancer.
    Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH
    World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.